West Pharmaceutical Services (NYSE:WST – Get Free Report) and Vivos Therapeutics (NASDAQ:VVOS – Get Free Report) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, institutional ownership, dividends, valuation and profitability.
Volatility and Risk
West Pharmaceutical Services has a beta of 1.13, suggesting that its stock price is 13% more volatile than the S&P 500. Comparatively, Vivos Therapeutics has a beta of 6.37, suggesting that its stock price is 537% more volatile than the S&P 500.
Analyst Recommendations
This is a breakdown of recent recommendations and price targets for West Pharmaceutical Services and Vivos Therapeutics, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| West Pharmaceutical Services | 0 | 1 | 13 | 0 | 2.93 |
| Vivos Therapeutics | 1 | 1 | 2 | 0 | 2.25 |
West Pharmaceutical Services currently has a consensus target price of $424.67, suggesting a potential upside of 2.96%. Vivos Therapeutics has a consensus target price of $2.80, suggesting a potential upside of 3,144.50%. Given Vivos Therapeutics’ higher probable upside, analysts plainly believe Vivos Therapeutics is more favorable than West Pharmaceutical Services.
Institutional & Insider Ownership
93.9% of West Pharmaceutical Services shares are held by institutional investors. Comparatively, 26.4% of Vivos Therapeutics shares are held by institutional investors. 0.6% of West Pharmaceutical Services shares are held by company insiders. Comparatively, 1.4% of Vivos Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Profitability
This table compares West Pharmaceutical Services and Vivos Therapeutics’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| West Pharmaceutical Services | 18.81% | 21.78% | 15.99% |
| Vivos Therapeutics | -122.00% | -2,325.64% | -102.01% |
Earnings & Valuation
This table compares West Pharmaceutical Services and Vivos Therapeutics”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| West Pharmaceutical Services | $3.07 billion | 9.35 | $493.70 million | $8.91 | 46.29 |
| Vivos Therapeutics | $17.44 million | 0.07 | -$21.17 million | ($1.90) | -0.05 |
West Pharmaceutical Services has higher revenue and earnings than Vivos Therapeutics. Vivos Therapeutics is trading at a lower price-to-earnings ratio than West Pharmaceutical Services, indicating that it is currently the more affordable of the two stocks.
Summary
West Pharmaceutical Services beats Vivos Therapeutics on 11 of the 14 factors compared between the two stocks.
About West Pharmaceutical Services
West Pharmaceutical Services designs and manufactures packaging components and delivery systems used by the pharmaceutical, biotechnology, and medical device industries. Its products help contain and administer injectable medicines and include elastomeric components, such as stoppers and seals, as well as syringe components and other packaging and delivery solutions. The company also provides contract manufacturing services for medical devices and pharmaceutical delivery systems. Its customers include companies developing and producing branded, generic, and biologic medicines.
About Vivos Therapeutics
Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing oral appliances and related treatments for sleep-disordered breathing, including obstructive sleep apnea (OSA) and snoring. Its approach is designed to help improve upper-airway function through non-surgical, dentist-supervised therapies. The company’s primary products are its Vivos Complete Airway Repositioning and Expansion (CARE) oral appliances, which are customized for individual patients and intended for use during sleep.
Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.
